These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. CD36/SR-B2-TLR2 Dependent Pathways Enhance Porphyromonas gingivalis Mediated Atherosclerosis in the Ldlr KO Mouse Model. Brown PM; Kennedy DJ; Morton RE; Febbraio M PLoS One; 2015; 10(5):e0125126. PubMed ID: 25938460 [TBL] [Abstract][Full Text] [Related]
28. Differential induction of endotoxin tolerance by lipopolysaccharides derived from Porphyromonas gingivalis and Escherichia coli. Martin M; Katz J; Vogel SN; Michalek SM J Immunol; 2001 Nov; 167(9):5278-85. PubMed ID: 11673543 [TBL] [Abstract][Full Text] [Related]
29. Porphyromonas gingivalis gingipains selectively reduce CD14 expression, leading to macrophage hyporesponsiveness to bacterial infection. Wilensky A; Tzach-Nahman R; Potempa J; Shapira L; Nussbaum G J Innate Immun; 2015; 7(2):127-135. PubMed ID: 25228314 [TBL] [Abstract][Full Text] [Related]
30. Porphyromonas gingivalis lipopolysaccharide activates canonical Wnt/β-catenin and p38 MAPK signalling in stem cells from the apical papilla. Wang J; Dai J; Liu B; Gu S; Cheng L; Liang J Inflammation; 2013 Dec; 36(6):1393-402. PubMed ID: 23818055 [TBL] [Abstract][Full Text] [Related]